Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chen, C.; Martinez, D. R.; Marti, M. M.; Schaefer, A.; Cheng, M. H.; Mannar, D.; Zhu, X.; Berezuk, A. M.; Banerjee, A.; Sobolewski, M. D.; Kim, A.; Treat, B. R.; Da Silva Castanha, P. M.; Enick, N.; McCormick, K. D.; Liu, X.; Adams, C.; Hines, M. G.; Sun, Z.; Chen, W.; Jacobs, J. L.; Barratt-Boyes, S. M.; Mellors, J. W.; Baric, R. S.; Bahar, I.; Dimitrov, D. S.; Subramaniam, S.; Saville, J. W.; Li, W.
Show abstract
The emergence of SARS-CoV-2 variants of concern (VOCs) requires the development of next-generation biologics that are effective against a variety of strains of the virus. Herein, we characterize a human VH domain, F6, which we generated by sequentially panning large phage displayed VH libraries against receptor binding domains (RBDs) containing VOC mutations. Cryo-EM analyses reveal that F6 has a unique binding mode that spans a broad surface of the RBD and involves the antibody framework region. Attachment of an Fc region to a fusion of F6 and ab8, a previously characterized VH domain, resulted in a construct (F6-ab8-Fc) that neutralized Omicron pseudoviruses with a half-maximal neutralizing concentration (IC50) of 4.8 nM in vitro. Additionally, prophylactic treatment using F6-ab8-Fc reduced live Beta (B.1.351) variant viral titers in the lungs of a mouse model. Our results provide a new potential therapeutic against SARS-CoV-2 VOCs - including the recently emerged Omicron variant - and highlight a vulnerable epitope within the spike protein RBD that may be exploited to achieve broad protection against circulating variants.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structurally related but genetically unrelated antibody lineages converge on an immunodominantHIV-1 Env neutralizing determinant following trimer immunization 96%
- A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant 96%
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates 96%
Similar papers in this journal
- Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity 96%
- A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo 96%
- Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin 96%
Similar papers in this journal
- Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination 96%
- Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition 96%
- Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift 96%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.